Leader Biopharma (00399.HK): Subscription price has been revised to HK$0.3124 per share, resuming trading on July 17th.

China Fortune Financial News APP: Navigation pharmaceutical bio-technology (00399.HK) announced that on July 16, 2025, the company entered into a supplemental agreement with subscriber A and a supplemental agreement with subscriber B. According to this, the subscription price has been revised to 0.3124 Hong Kong dollars per share, a discount of about 19.89% compared to the closing price of 0.39 Hong Kong dollars per share on July 15, 2025.